Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Rogers, Laura Q University Of Alabama At Birmingham United States Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors 5R01CA235598-06 Gabriela Riscuta, M.D., CNS Ross, Stephen New York University School Of Medicine United States Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress 5R01CA268521-04 Rachel Altshuler, Ph.D. Ross, Stephen New York University School Of Medicine United States Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress 5R01CA268521-04 Rachel Altshuler, Ph.D. Roth, Michael E. Public Health Institute United States Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant 3UG1CA189955-11S3 Brandy Heckman-Stoddard, Ph.D., M.P.H. Roth, Michael E. Public Health Institute United States Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant 3UG1CA189955-11S3 Brandy Heckman-Stoddard, Ph.D., M.P.H. Rowland, Kendrith Martin Carle Foundation United States Carle Cancer Center NCI Community Oncology Research Program (NCORP) 3UG1CA189861-11S1 Vanessa A. White, M.P.H. Rowland, Kendrith Martin Carle Foundation United States Carle Cancer Center NCI Community Oncology Research Program (NCORP) 3UG1CA189861-11S1 Vanessa A. White, M.P.H. Salman, Emad Florida Assn Of Pediatric Tumor Prog United States The Florida Pediatric NCORP: NCI Community Oncology Research Program. 3UG1CA189973-11S1 Vanessa A. White, M.P.H. Salman, Emad Florida Assn Of Pediatric Tumor Prog United States The Florida Pediatric NCORP: NCI Community Oncology Research Program. 3UG1CA189973-11S1 Vanessa A. White, M.P.H. Salvemini, Daniela Saint Louis University United States Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D. Salvemini, Daniela Saint Louis University United States Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D. Sands, Stephen Alan Sloan-Kettering Inst Can Research United States Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D. Sands, Stephen Alan Sloan-Kettering Inst Can Research United States Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D. Sands, Stephen Alan Sloan-Kettering Inst Can Research United States Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D. Santomasso, Bianca Denise Sloan-Kettering Inst Can Research United States Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy 5R01CA293922-02 Monica Epstein, B.S.N., RN, OCN Pagination « First First page ‹ Previous Previous page … 19 20 21 22 … Next › Next page Last » Last page
